170 related articles for article (PubMed ID: 12139465)
1. Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase.
Hernick M; Flader C; Borch RF
J Med Chem; 2002 Aug; 45(16):3540-8. PubMed ID: 12139465
[TBL] [Abstract][Full Text] [Related]
2. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
Flader C; Liu J; Borch RF
J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.
Steinberg G; Borch RF
J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089
[TBL] [Abstract][Full Text] [Related]
4. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
Wu X; Hu L
Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation.
Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J
Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199
[TBL] [Abstract][Full Text] [Related]
9. Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs.
Cytarska J; Misiura K; Filip-Psurska B; Wietrzyk J
Acta Pol Pharm; 2013; 70(3):481-7. PubMed ID: 23757939
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
Roth T; Tang W; Eisenbrand G
Anticancer Drug Des; 1995 Dec; 10(8):655-66. PubMed ID: 8595124
[TBL] [Abstract][Full Text] [Related]
11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
12. Phthalimide analogs of CB 1954: synthesis and bioactivation.
Mehta LK; Hobbs S; Chen S; Knox RJ; Parrick J
Anticancer Drugs; 1999 Sep; 10(8):777-83. PubMed ID: 10573210
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
14. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
Wang YQ; Farquhar D
J Med Chem; 1991 Jan; 34(1):197-203. PubMed ID: 1992116
[TBL] [Abstract][Full Text] [Related]
15. INDQ/NO, a bioreductively activated nitric oxide prodrug.
Sharma K; Iyer A; Sengupta K; Chakrapani H
Org Lett; 2013 Jun; 15(11):2636-9. PubMed ID: 23659457
[TBL] [Abstract][Full Text] [Related]
16. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
Kwon CH; Moon KY; Baturay N; Shirota FN
J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
Lin S; Li Y; Zheng Y; Luo L; Sun Q; Ge Z; Cheng T; Li R
Eur J Med Chem; 2017 Feb; 127():442-458. PubMed ID: 28092860
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanisms of activation of indolequinone phosphoramidate prodrugs.
Hernick M; Borch RF
J Med Chem; 2003 Jan; 46(1):148-54. PubMed ID: 12502368
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
Bailey SM; Suggett N; Walton MI; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
Tobias SC; Borch RF
J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
